---

• n  leukemia characterized by enlargement of lymphoid tissues and lymphocytic cells in the circulating blood

News & Articles

---

• AbbVie announces preliminary results in Phase 1 study of ABT-199
  AbbVie announced preliminary results from a Phase I study of ABT-199/GDC-0199, an investigational BCL-2 selective inhibitor, in patients with high-risk relapsed/refractory chronic lymphocytic leukemia, ...
  June 17, 2013 - Theflyonthewall.com via Yahoo! Finance